Zoe Vetter

Blazhynska, M.; Adjoua, O.; Vetter, Z.A.; Lagardere, L.; Piquemal, J.P. Satellite Tobacco Mosaic Virus: Revealing Environmental Drivers of Capsid and Nucleocapsid Plasticity using High-Resolution Simulations, Ver. 4. bioRxiv (preprint), October 31 2025. DOI: 10.1101/2025.01.28.635309

Caputa, D.A.; Blankenship, Q.P.; Smith, Z.D.; Huebner, M.M.; Vetter, Z.A.; Parks, R.W.; Armendariz Lobera, S.; Leddin, E.M.; Taylor, C.A.; Parish, C.A.; Miller, B.R. Computational Drug Discovery of an Inhibitor of APOBEC3B as a Treatment for Epithelial Cancers. J. Biomol. Struct. Dyn., 2023, 1–14. DOI: 10.1080/07391102.2023.2293269

Vetter, Z.A.; Miller, B.R. (Oral Presentation) Inhibiting the KIX to c-Myb interaction as a potential treatment for leukemia.Truman State University Student Research Conference, Kirksville, MO, April 18, 2024.

Vetter, Z.A.; Boyn, J.N. (Poster) Computational Benchmarking of Magnetic Exchange Couplings for Transition Metal Dimers. Midwest Theoretical Chemistry Conference 56, Minneapolis, MN, May 21, 2026.

Vetter, Z.A.; Bromfman, M.; Miller, B.R. (Poster) Computational discovery of an inhibitor of the c-Myb/KIX complex as a potential treatment for AML. American Chemical Society (ACS) Spring 2025, San Diego, CA, March 25, 2025. (Recognition for Outstanding Research, ACS COMP Division)

Vetter, Z.A.; Ede, R.E.; Pomerantz, W.C.K. (Poster) Progress Towards Developing a Targeted Covalent Inhibitor of PCAF. American Chemical Society (ACS) Spring 2025, San Diego, CA, March 24, 2025.

Vetter, Z.A.; Ede, R.E.; Pomerantz, W.C.K. (Poster) Progress Towards Developing a Targeted Covalent Inhibitor of PCAF. Summer Undergraduate Research Expo (SURE), University of Minnesota–Twin Cities, Minneapolis, Minnesota, August 8, 2024.

Vetter, Z.A.; Adjoua, O.; Lagardère, L.; Piquemal, J.P. (Poster) Simulating the Satellite Tobacco Mosaic Virus using the AMOEBA polarizable force field and Tinker-HP MD package. American Chemical Society (ACS) Spring 2024, New Orleans, LA, March 19, 2024.

Vetter, Z.A.; Miller, B.R. (Poster) Modeling disruption of the KIX/c-Myb complex: a possible leukemia therapy. ACS Spring 2024, New Orleans, LA, March 19, 2024.

Vetter, Z.A.; Miller, B.R. (Poster) Modeling disruption of the KIX/c-Myb complex as a potential leukemia treatment. Interdisciplinary Biomedical Research Symposium, A.T. Still Research Institute, November 11, 2023. (Jack Magruder Award for Best Undergraduate Poster)

Caputa, D.A.; Vetter, Z.A.; Miller, B.R. (Poster) Computational drug discovery of APOBEC3B inhibitors as a treatment for epithelial cancers. ACS Spring 2023, Indianapolis, IN, March 28, 2023. (Recognition for Outstanding Research, ACS COMP Division)